Sunday, September 20, 2026

Expedia Group Stock Over 15% Down So Far Today

Expedia Group Stock Over 15% Down So Far Today

Expedia Group (NASDAQ: EXPE), a renowned online travel company, experienced a significant setback as its shares took an astonishing dip of 15.53% as of 11:29 am ET on Thursday morning. This staggering decline adds to the company's ongoing downward trend, echoing the results of two prior consecutive sessions with losses on NASDAQ, which also bore witness to a minor dip of 0.12%.

Current and Previous Performances

Expedia managed to paint a clear image of its past and ongoing performance by winding up the last session at a rate 5.56% below its 52-week high. The company, operating under various globally recognized brands such as Brand Expedia, Hotels.com, Orbitz, and Trivago, has strived to carve a niche for itself in the domestic and global online travel sector. Despite its efforts, however, its stocks have suffered a significant hit.

Fundamentals Analysis

A comprehensive examination of the company's fundamentals show an earnings per share (EPS) figure of $2.96 over its trailing twelve month earnings period and an investment potential ratio of 50.85. This suggests an estimated investment return on every dollar of annual earnings; a proposition that may not be enticing enough for potential investors, given the current performance of the business. The Return on Equity (ROE), a measure of profitability relative to shareholder equity, stands at 9.51% for the trailing twelve month period.

Recent Instability

Over the past week, the company's stocks have shown some degree of instability, as reflected in the negative intraday variation averages and marginally positive averages in ensuing months and quarters. Judging by their valuation, Expedia Group stocks appear overbought, as divulged by their stochastic oscillator, which typically signifies impending pullbacks.

Growth Projections

Notwithstanding these hurdles, the company's earnings before interest, taxes, depreciation, and amortization (EBITDA) stand at a remarkable 88.15. The growth estimates for the present and coming quarter are pegged at 18.4% and 31.9% respectively. Despite housing a diverse brand portfolio and promising growth forecasts, Expedia Group's current underperformance in the stock market hints at investor hesitation.

Conclusion

Expedia's high P/E ratio, coupled with potential overbought conditions, exacerbates this situation further. Thus, despite its established presence and growth trajectories, investors seem to be approaching with caution, reflecting in its stocks' performance.

More news about Expedia Group (EXPE).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com